Immunogenicity of a Meningococcal B Vaccine during a University Outbreak

BACKGROUND: In December 2013, a multicomponent meningococcal serogroup B (4CMenB) vaccine was used before licensure on the basis of special consideration by the Food and Drug Administration to respond to an outbreak of Neisseria meningitidis B at a U.S. university. Data suggested that vaccination wo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:N Engl J Med
Asıl Yazarlar: Basta, Nicole E., Mahmoud, Adel A.F., Wolfson, Julian, Ploss, Alexander, Heller, Brigitte L., Hanna, Sarah, Johnsen, Peter, Izzo, Robin, Grenfell, Bryan T., Findlow, Jamie, Bai, Xilian, Borrow, Ray
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4992664/
https://ncbi.nlm.nih.gov/pubmed/27468058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1514866
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller